Alessandra Vultaggio to Prognosis
This is a "connection" page, showing publications Alessandra Vultaggio has written about Prognosis.
Connection Strength
0.008
-
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders. J Allergy Clin Immunol Pract. 2018 Nov - Dec; 6(6):2065-2072.e2.
Score: 0.008